Vontobel Holding Ltd. Sells 340 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Vontobel Holding Ltd. cut its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 11.8% in the 3rd quarter, Holdings Channel reports. The firm owned 2,549 shares of the company’s stock after selling 340 shares during the period. Vontobel Holding Ltd.’s holdings in Addus HomeCare were worth $339,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in shares of Addus HomeCare by 1.5% in the 1st quarter. Vanguard Group Inc. now owns 1,276,467 shares of the company’s stock valued at $131,910,000 after acquiring an additional 19,027 shares during the last quarter. Point72 Asset Management L.P. lifted its stake in shares of Addus HomeCare by 73.4% in the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after acquiring an additional 315,602 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Addus HomeCare by 0.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock valued at $82,930,000 after acquiring an additional 5,421 shares during the last quarter. Principal Financial Group Inc. lifted its stake in shares of Addus HomeCare by 20.9% in the 2nd quarter. Principal Financial Group Inc. now owns 430,444 shares of the company’s stock valued at $49,979,000 after acquiring an additional 74,488 shares during the last quarter. Finally, Millennium Management LLC lifted its stake in shares of Addus HomeCare by 412.7% in the 2nd quarter. Millennium Management LLC now owns 316,418 shares of the company’s stock valued at $36,739,000 after acquiring an additional 254,705 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Trading Down 0.7 %

Shares of Addus HomeCare stock opened at $130.08 on Wednesday. The business has a 50-day moving average price of $130.61 and a two-hundred day moving average price of $118.77. Addus HomeCare Co. has a 1-year low of $78.35 and a 1-year high of $136.12. The company has a market cap of $2.35 billion, a P/E ratio of 32.28, a PEG ratio of 2.33 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, August 5th. The company reported $1.35 EPS for the quarter, beating the consensus estimate of $1.21 by $0.14. The company had revenue of $286.90 million during the quarter, compared to the consensus estimate of $284.90 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The firm’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the business posted $0.94 EPS. Equities research analysts forecast that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on ADUS shares. StockNews.com cut Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 7th. TD Cowen increased their price objective on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a report on Thursday, August 8th. KeyCorp assumed coverage on Addus HomeCare in a report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price objective for the company. Stephens restated an “overweight” rating and issued a $138.00 price objective on shares of Addus HomeCare in a report on Tuesday, August 6th. Finally, Macquarie restated an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a report on Friday, October 11th. One investment analyst has rated the stock with a sell rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Addus HomeCare has a consensus rating of “Moderate Buy” and a consensus target price of $131.38.

Insider Activity at Addus HomeCare

In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the transaction, the director now directly owns 3,366 shares in the company, valued at approximately $429,165. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 22,917 shares of company stock valued at $3,050,082. 4.60% of the stock is owned by corporate insiders.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.